The Ontological Tourism Problem in Psychedelic Science
Abstract
1. Introduction
2. When Does Phenomenology Justify Ontological Inference?
3. The Convergence Argument
4. Illusion, False Belief, and Ontological Shock
5. Why Ontological Tourism Matters
6. The Epistemic Contribution of Psychedelic Phenomenology
7. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Carhart-Harris, R.; Giribaldi, B.; Watts, R.; Baker-Jones, M.; Murphy-Beiner, A.; Murphy, R.; Martell, J.; Blemings, A.; Erritzoe, D.; Nutt, D.J. Trial of Psilocybin versus Escitalopram for Depression. N. Engl. J. Med. 2021, 384, 1402–1411. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lawrence, D.W.; Carhart-Harris, R.; Griffiths, R.; Timmermann, C. Phenomenology and content of the inhaled N,N-dimethyltryptamine (N,N-DMT) experience. Sci. Rep. 2022, 12, 8562. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lawrence, D.W.; DiBattista, A.P.; Timmermann, C. N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q). J. Psychoact. Drugs 2023, 56, 443–455. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Davis, A.K.; Clifton, J.M.; Weaver, E.G.; Hurwitz, E.S.; Johnson, M.W.; Griffiths, R.R. Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. J. Psychopharmacol. 2020, 34, 1008–1020. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Martial, C.; Carhart-Harris, R.; Timmermann, C. Within-subject comparison of near-death and psychedelic experiences: Acute and enduring effects. Neurosci. Conscious. 2024, 2024, niae033. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Timmermann, C.; Roseman, L.; Williams, L.; Erritzoe, D.; Martial, C.; Cassol, H.; Laureys, S.; Nutt, D.; Carhart-Harris, R. DMT Models the Near-Death Experience. Front. Psychol. 2018, 9, 1424. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Griffiths, R.; Richards, W.; Johnson, M.; McCann, U.; Jesse, R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J. Psychopharmacol. 2008, 22, 621–632. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Griffiths, R.R.; Hurwitz, E.S.; Davis, A.K.; Johnson, M.W.; Jesse, R. Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLoS ONE 2019, 14, e0214377. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gallimore, A.R.; Hoffman, D.D.; Hermansson, N. Traces of the Other—Are DMT Entities Real? DMT Phenomenology in the Framework of Conscious Realism. PsyArXiv 2026. [Google Scholar] [CrossRef] [Scilit]
- Timmermann, C.; Bauer, P.R.; Gosseries, O.; Vanhaudenhuyse, A.; Vollenweider, F.; Laureys, S.; Singer, T.; Mind and Life Europe (MLE) ENCECON Research Group; Antonova, E.; Lutz, A. A neurophenomenological approach to non-ordinary states of consciousness: Hypnosis, meditation, and psychedelics. Trends Cogn. Sci. 2023, 27, 139–159. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Winkelman, M.J. An ontology of psychedelic entity experiences in evolutionary psychology and neurophenomenology. J. Psychedelic Stud. 2018, 2, 5–23. [Google Scholar] [CrossRef] [Scilit]
- Timmermann, C.; Sanders, J.W.; Reydellet, D.; Barba, T.; Luan, L.X.; Angona, O.S.; Ona, G.; Allocca, G.; Smith, C.H.; Daily, Z.G.; et al. Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness. Neurosci. Conscious. 2025, 2025, niaf007. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sanders, J.W.; Milliere, R.; Demsar, E.; Daily, Z.G.; Erritzoe, D.; Carhart-Harris, R.; Timmermann, C. Micro-phenomenology of immersion and perceived presences under DMT. Neurosci. Conscious. 2026, 2026, niag015. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Letheby, C. Philosophy of Psychedelics; Oxford University Press: Oxford, UK, 2021. [Google Scholar]
- Valera, F.J. Neurophenomenology: A Methodological Remedy for the Hard Problem. J. Conscious. Stud. 1996, 3, 330–349. [Google Scholar]
- Timmermann, C.; Roseman, L.; Haridas, S.; Rosas, F.E.; Luan, L.; Kettner, H.; Martell, J.; Erritzoe, D.; Tagliazucchi, E.; Pallavicini, C.; et al. Human brain effects of DMT assessed via EEG-fMRI. Proc. Natl. Acad. Sci. USA 2023, 120, e2218949120. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Pallavicini, C.; Cavanna, F.; Zamberlan, F.; de la Fuente, L.A.; Arias, M.; Romero, C.; Carhart-Harris, R.; Timmermann, C.; Tagliazucchi, E. Neural and subjective effects of inhaled DMT in natural settings. bioRxiv 2020. [Google Scholar] [CrossRef] [Scilit]
- Valle, M.; Maqueda, A.E.; Rabella, M.; Rodriguez-Pujadas, A.; Antonijoan, R.M.; Romero, S.; Alonso, J.F.; Mananas, M.A.; Barker, S.; Friedlander, P.; et al. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. Eur. Neuropsychopharmacol. 2016, 26, 1161–1175. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Carhart-Harris, R.L.; Muthukumaraswamy, S.; Roseman, L.; Kaelen, M.; Droog, W.; Murphy, K.; Tagliazucchi, E.; Schenberg, E.E.; Nest, T.; Orban, C.; et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc. Natl. Acad. Sci. USA 2016, 113, 4853–4858. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lebedev, A.V.; Lovden, M.; Rosenthal, G.; Feilding, A.; Nutt, D.J.; Carhart-Harris, R.L. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Hum. Brain Mapp. 2015, 36, 3137–3153. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Irrmischer, M.; Aqil, M.; Luan, L.; Wang, T.; Engelbregt, H.; Carhart-Harris, R.; Linkenkaer-Hansen, K.; Timmermann, C. DMT-Induced Shifts in Criticality Correlate with Self-Dissolution. J. Neurosci. 2026, 46, e0344252025. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Argyri, E.K.; Evans, J.; Luke, D.; Michael, P.; Michelle, K.; Rohani-Shukla, C.; Suseelan, S.; Prideaux, E.; McAlpine, R.; Murphy-Beiner, A.; et al. Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences. PLoS ONE 2025, 20, e0322501. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Griffiths, R.R.; Richards, W.A.; McCann, U.; Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 2006, 187, 268–283; discussion 284–292. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Luke, D. Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology and ontology. J. Soc. Psych. Res. 2011, 75, 26–42. [Google Scholar]
- Michael, P.; Luke, D.; Robinson, O. An Encounter with the Other: A Thematic and Content Analysis of DMT Experiences from a Naturalistic Field Study. Front. Psychol. 2021, 12, 720717. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Michael, P.; Luke, D.; Robinson, O. An encounter with death: A comparative thematic and content analysis of naturalistic DMT experiences and the near-death experience. Front. Psychol. 2025, 16, 1532937. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Seth, A.K.; Bayne, T. Theories of consciousness. Nat. Rev. Neurosci. 2022, 23, 439–452. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kastrup, B. Analytic Idealism: A Consciousness-Only Ontology; PhilPapers: London, ON, Canada, 2019. [Google Scholar]
- Godfrey-Smith, P. Theory and Reality: An Introduction to the Philosophy of Science; University of Chicago Press: Chicago, IL, USA, 2009. [Google Scholar]
- Van Fraassen, B.C. The Scientific Image; Oxford University Press: Oxford, UK, 1980. [Google Scholar]
- Watts, R.; Kettner, H.; Geerts, D.; Gandy, S.; Kartner, L.; Mertens, L.; Timmermann, C.; Nour, M.M.; Kaelen, M.; Nutt, D.; et al. The Watts Connectedness Scale: A new scale for measuring a sense of connectedness to self, others, and world. Psychopharmacology 2022, 239, 3461–3483. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alamia, A.; Timmermann, C.; Nutt, D.J.; VanRullen, R.; Carhart-Harris, R.L. DMT alters cortical travelling waves. eLife 2020, 9, e59784. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Siegel, J.S.; Subramanian, S.; Perry, D.; Kay, B.P.; Gordon, E.M.; Laumann, T.O.; Reneau, T.R.; Metcalf, N.V.; Chacko, R.V.; Gratton, C.; et al. Psilocybin desynchronizes the human brain. Nature 2024, 632, 131–138. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Carhart-Harris, R.L.; Friston, K.J. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. Pharmacol. Rev. 2019, 71, 316–344. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hartogsohn, I. Constructing drug effects: A history of set and setting. Drug Sci. Policy Law 2017, 3, 2050324516683325. [Google Scholar] [CrossRef] [Scilit]
- Hartogsohn, I. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. J. Psychopharmacol. 2016, 30, 1259–1267. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yildirim, B.; Sahin, S.S.; Gee, A.; Jauhar, S.; Rucker, J.; Salgado-Pineda, P.; Pomarol-Clotet, E.; McKenna, P. Adverse psychiatric effects of psychedelic drugs: A systematic review of case reports. Psychol. Med. 2024, 54, 4035–4047. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- James, W. The Varieties of Religious Experience; Oxford University Press: Oxford, UK, 1902. [Google Scholar]
- Proudfoot, W. Religious Experience; University of California Press: Oakland, CA, USA, 1985. [Google Scholar]
- Taves, A. Religious Experience Reconsidered: A Building-Block Approach to the Study of Religion and Other Special Things; Princeton University Press: Princeton, NJ, USA, 2009. [Google Scholar] [CrossRef] [Scilit]
- Alston, W.P. Perceiving God: The Epistemology of Religious Experience; Cornell University Press: Ithaca, NY, USA, 1991. [Google Scholar]
- Stace, W.T. Mysticism and Philosophy; St. Martin’s Press: New York, NY, USA, 1960. [Google Scholar]
- Katz, S.T. Mysticism and Philosophical Analysis; Oxford University Press: New York, NY, USA, 1978. [Google Scholar]
- McGovern, H.T.; Grimmer, H.J.; Doss, M.K.; Hutchinson, B.T.; Timmermann, C.; Lyon, A.; Corlett, P.R.; Laukkonen, R.E. An Integrated theory of false insights and beliefs under psychedelics. Commun. Psychol. 2024, 2, 69. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Griffiths, R.R.; Johnson, M.W.; Richards, W.A.; Richards, B.D.; Jesse, R.; MacLean, K.A.; Barrett, F.S.; Cosimano, M.P.; Klinedinst, M.A. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J. Psychopharmacol. 2018, 32, 49–69. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cole-Turner, R. Psychedelic Epistemology: William James and the “Noetic Quality” of Mystical Experience. Religions 2021, 12, 1058. [Google Scholar] [CrossRef] [Scilit]
- Fleming, S.M.; Daw, N.D. Self-evaluation of decision-making: A general Bayesian framework for metacognitive computation. Psychol. Rev. 2017, 124, 91–114. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Seth, A.K.; Friston, K.J. Active interoceptive inference and the emotional brain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2016, 371, 20160007. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Timmermann, C.; Kettner, H.; Letheby, C.; Roseman, L.; Rosas, F.E.; Carhart-Harris, R.L. Psychedelics alter metaphysical beliefs. Sci. Rep. 2021, 11, 22166. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Borkel, L.F.; Rojas-Hernandez, J.; Quintana-Hernandez, D.J.; Henriquez-Hernandez, L.A. Therapeutic benefit versus epistemic risk: Need for empirical research in psychedelic epistemology. J. Psychiatr. Res. 2025, 188, 117–125. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Doss, M.K.; Weafer, J.; Gallo, D.A.; de Wit, H. MDMA Impairs Both the Encoding and Retrieval of Emotional Recollections. Neuropsychopharmacology 2018, 43, 791–800. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Doss, M.K.; Mallaroni, P.; Mason, N.L.; Ramaekers, J.G. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2024, 9, 1048–1057. [Google Scholar] [CrossRef] [Scilit]
- Kangaslampi, S.; Wolff, M.; Doss, M.K.; Kloft-Heller, L.; Otgaar, H. Questioning the recovery of dissociated traumatic memories under psilocybin: Comment on “Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa”. J. Eat. Disord. 2025, 13, 278. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bortolotti, L. The epistemic innocence of motivated delusions. Conscious. Cogn. 2015, 33, 490–499. [Google Scholar] [CrossRef] [Scilit]
- Lawrence, D.W.; Sharma, B.; Griffiths, R.R.; Carhart-Harris, R. Trends in the Top-Cited Articles on Classic Psychedelics. J. Psychoact. Drugs 2021, 53, 283–298. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Carhart-Harris, R.L.; Bolstridge, M.; Rucker, J.; Day, C.M.; Erritzoe, D.; Kaelen, M.; Bloomfield, M.; Rickard, J.A.; Forbes, B.; Feilding, A.; et al. Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. Lancet Psychiatry 2016, 3, 619–627. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yao, Y.; Guo, D.; Lu, T.S.; Liu, F.L.; Huang, S.H.; Diao, M.Q.; Li, S.X.; Zhang, X.J.; Kosten, T.R.; Shi, J.; et al. Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis. Psychiatry Res. 2024, 335, 115886. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yaden, D.B.; Griffiths, R.R. The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects. ACS Pharmacol. Transl. Sci. 2021, 4, 568–572. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Watts, R.; Luoma, J.B. The use of the psychological flexibility model to support psychedelic assisted therapy. J. Context. Behav. Sci. 2020, 15, 92–102. [Google Scholar] [CrossRef] [Scilit]
- Gorman, I.; Nielson, E.M.; Molinar, A.; Cassidy, K.; Sabbagh, J. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Front. Psychol. 2021, 12, 645246. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Brennan, W.; Belser, A.B. Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. Front. Psychol. 2022, 13, 866018. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Girn, M.; Rosas, F.E.; Daws, R.E.; Gallen, C.L.; Gazzaley, A.; Carhart-Harris, R.L. A complex systems perspective on psychedelic brain action. Trends Cogn. Sci. 2023, 27, 433–445. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Lawrence, D.W. The Ontological Tourism Problem in Psychedelic Science. Psychoactives 2026, 5, 19. https://doi.org/10.3390/psychoactives5030019
Lawrence DW. The Ontological Tourism Problem in Psychedelic Science. Psychoactives. 2026; 5(3):19. https://doi.org/10.3390/psychoactives5030019
Chicago/Turabian StyleLawrence, David Wyndham. 2026. "The Ontological Tourism Problem in Psychedelic Science" Psychoactives 5, no. 3: 19. https://doi.org/10.3390/psychoactives5030019
APA StyleLawrence, D. W. (2026). The Ontological Tourism Problem in Psychedelic Science. Psychoactives, 5(3), 19. https://doi.org/10.3390/psychoactives5030019

